Literature DB >> 3162916

Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.

F Macdonald1, R Bird, H Stokes, B Russell, J Crocker.   

Abstract

The expression of five different antigens in ovarian tumours was studied by means of an immunohistochemical test with anti-CEA, HMFG1 and HMFG2, NS19-9 and OC125 antibodies. Considerable variation was noted not only between different histological types and between tumours of one type but also between areas in a single tumour. HMFG1 and HMFG2 were the most reactive of all the antibodies; NS19-9 and OC125 were expressed by different populations of cells. It is concluded that specific combinations of antibodies are more effective both for the monitoring of ovarian cancer as well as for immunodiagnosis and treatment, than any single one used.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162916      PMCID: PMC1141420          DOI: 10.1136/jcp.41.3.260

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Carcinoembryonic antigen in human ovarian neoplasms.

Authors:  A Marchand; C M Fenoglio; R Pascal; R M Richart; S Bennett
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

2.  Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen.

Authors:  J R van Nagell; E Kim; S Casper; F J Primus; S Bennett; F H DeLand; D M Goldenberg
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

3.  Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.

Authors:  A A Epenetos; K E Britton; S Mather; J Shepherd; M Granowska; J Taylor-Papadimitriou; C C Nimmon; H Durbin; L R Hawkins; J S Malpas; W F Bodmer
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

4.  Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon-specific antigen-p (CSAp).

Authors:  S A Gaffar; K D Pant; D Shochat; S J Bennett; D M Goldenberg
Journal:  Int J Cancer       Date:  1981-01-15       Impact factor: 7.396

5.  Multiple biochemical markers in patients with gynecologic malignancies.

Authors:  E S Donaldson; J R van Nagell; S Pursell; E C Gay; W R Meeker; R Kashmiri; J van deVoorde
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

6.  Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.

Authors:  C Charpin; A K Bhan; V R Zurawski; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1982       Impact factor: 2.762

7.  Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.

Authors:  K E Stall; E W Martin
Journal:  J Reprod Med       Date:  1981-02       Impact factor: 0.142

8.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

9.  Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels.

Authors:  C H Ford; H J Stokes; C E Newman
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

10.  A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.

Authors:  B Dhokia; P A Canney; D Pectasides; A J Munro; M Moore; P M Wilkinson; C Self; A A Epenetos
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

View more
  2 in total

1.  Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.

Authors:  O Mogensen; B Mogensen; A Jakobsen
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

2.  Expression of CA125 in pancreatic carcinoma and chronic pancreatitis.

Authors:  F Macdonald; R Downing; W H Allum
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.